Cdx2 as a marker for neuroendocrine tumors of unknown primary sites

Endocrine Pathology

Volumn 15, Issue 3, 2004, Pages 247-252

  Erickson, Lori A ^a   Papouchado, Bettina ^a   Dimashkieh, Haytham ^a   Zhang, Shuya ^a   Nakamura, Nobuki ^a   Lloyd, Ricardo V ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Carcinoid tumor; Cdx2; Neuroendocrine

Indexed keywords

TRANSCRIPTION FACTOR CDX2; TUMOR MARKER;

ARTICLE; CARCINOID; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SMALL INTESTINE TUMOR; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOID TUMOR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASMS, UNKNOWN PRIMARY; NEUROENDOCRINE TUMORS; TUMOR MARKERS, BIOLOGICAL;

EID: 12844254318     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:15:3:247     Document Type: Article

References (26)

1. Lloyd RV, Osamura RY. Transcription factors in normal and neoplastic pituitary tissues. Review Microsc Res Tech 39:168-181, 1997.
2. Lau SK, Luthringer DJ, Eisen RN. Thyroid transcription factor-1. A review. Appl Immunohistochem Mol Morphol 19:97-102, 2003.
3. Sebine JN, Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. Review J Clin Pathol 56:412-416, 2003.
4. Agoff SN, Lamps LW, Philp AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 13:238-242, 2000.
5. Folpe AL, Gown AM, Lamps LW, et al. Thyroid transcription factor-1: immunohis-tochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 12:5-8, 2000.
6. Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 25:815-819, 2001.
7. Barbareschi M, Murer B, Colby TV, et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol 27:141-149, 2003.
8. Silberg DG, Swain GP, Suh ER, Traber PG. Cdx1 and Cdx2 expression during intestinal development. Gastroenterology 119:961-971, 2000.
9. Moskaluk CA, Zhang H, Powell SM, Cerilli LA, Hampton GM, Frierson HF, Jr. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol 16:913-919, 2003.
10. LaRosa S, Rigoli E, Uccella S, Capella C. CDX2 is a marker of midgut EC-cell tumors and their metastases. Mod Pathol 17 (Supplement 1): 105A (Abstract 434), 2004.
11. Lin X, Luckasevic T, Silverman JF, et al. Diagnostic Value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin. Mod Pathol 17 (Supplement 1): 106 (Abstract 435), 2004.
12. Luckasevic TM, Silverman JF, Medich D, Celebrezze J, Tung MT, Liu YL. Diagnostic value of CDX-2 expression in endocrine neoplasms of gastrointestinal origin. Mod Pathol 17 (Supplement 1): 106A (Abstract 437), 2004.
13. Barbareshi M, Roldo C, Zamboni G, et al. CDX-2 homeobox gene product expression in neuroendocrine tumors. Its role as a marker of intestinal neuroendocrine tumors. Mod Pathol 17 (Supplement 1): 106 (Abstract 417), 2004.
14. Subramanian V, Meyer B, Evans GS. The murine Cdx1 gene product localizes to the proliferative compartment in the developing and regenerating intestinal epithelium. Differentiation 64:11-18, 1998.
15. James R, Kazenwadel J. Homeobox gene expression in the intestinal epithelium of adult mice. J Biol Chem 266:3246-3251, 1991.
16. Eda A, Osawa H, Satoh K, et al. Aberrant expression of CDX-2 in Barren's epithelium and inflammatory esophageal mucosa. J Gastroenterol 38:14-22, 2003.
17. Almeida R, Silva E, Santos-Silva F, et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 199:36-40, 2003.
18. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 27:303-310, 2003.
19. Riss D, Jin L, Qian X, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res 63:2251-2255, 2003.
20. Lloyd RV, Vidal S, Jin L, et al. Myosin XVA expression in the pituitary and in other neuroendocrine tissues and tumors. Am J Pathol 159:1375-1382, 2001.
21. Beck F, Tata F, Chawengsaksophak K. Homebox genes and gut development. Bioessays 22:431-441, 2000.
22. Lohnes D. The Cdx1 homeodomain protein: an integrator of posterior signaling in the mouse. Bioessays 25:971-980, 2003.
23. Mitchelmore C, Troelsen JT, Spdsberg N, Sjostrom H, Noren O. Interaction between the homeodomain proteins Cdx2 and HNF1 alpha mediates expression of lactase-phlorizin hydrolase gene. Biochem J 346(Pt 2):529-535, 2000.
24. Bonhomme C, Duluc I, Martin E, et al. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 52:1465-1471, 2003.
25. Pearse AG. The diffuse neuroendocrine system peptides, aminos, placodes and the APUD theory. Prog Brain Res 68:25-31, 1986.
26. Pearse AG. Calcitonin and the C-cells. Role models for the neuroendocrine system. Bone Miner 16:166-168, 1992.